title: Importance of interaction between nerve growth factor and α9β1 integrin in glial tumor angiogenesis.
abstract: NGF is a growth factor for which the role in the promotion of angiogenesis is still not completely understood. We found that NGF promotes the pathological neovascularization process in glioma through a direct interaction with α9β1 integrin, which is up-regulated on microvascular endothelial cells in cancer tissue. We propagated gHMVEC primary cells using a new method of immune-selection, and these cells demonstrated α9β1 integrin-dependent binding of NGF in a cell adhesion assay. Moreover, NGF induced gHMVEC proliferation and chemotaxis inhibited by specific blockers of α9β1 integrin, such as MLD-disintegrins and monoclonal antibody Y9A2. A Matrigel tube formation assay revealed that NGF significantly increased capillary-like growth from gHMVEC to a level comparable to treatment with VEGF. The snake venom disintegrin, VLO5, inhibited the agonistic effect of both growth factors, whereas the effect of Y9A2 was not statistically significant. Angiogenesis exogenously induced by NGF  was also α9β1-integrin dependent in an embryonic quail CAM system. However, angiogenesis pathologically induced by developing glioma in this system was only sensitive for inhibition with MLD-disintegrin, suggesting a more complex effect of cancer cells on the neovascularization process. The anti-angiogenic effect of MLD-disintegrins is probably related to their pro-apoptotic ability induced in activated tumoral endothelial cells. Therefore, the molecular basis of these disintegrins may be useful for developing new angiostatic pharmaceuticals for application in cancer therapy.
authors.affiliation: Department of Biology Temple University Hospital, Philadelphia, PA 19122, USA.
authors.forename: Erin M
authors.initials: EM
authors.lastname: Walsh
authors.forename: Richard
authors.initials: R
authors.lastname: Kim
authors.forename: Luis
authors.initials: L
authors.lastname: Del Valle
authors.forename: Michael
authors.initials: M
authors.lastname: Weaver
authors.forename: Joel
authors.initials: J
authors.lastname: Sheffield
authors.forename: Philip
authors.initials: P
authors.lastname: Lazarovici
authors.forename: Cezary
authors.initials: C
authors.lastname: Marcinkiewicz
mesh_terms: D000818:Animals; D001921:Brain / Q000378:metabolism / Q000473:pathology; D001932:Brain Neoplasms / Q000098:blood supply / Q000378:metabolism / Q000473:pathology; D002448:Cell Adhesion; D045744:Cell Line, Tumor; D002465:Cell Movement; D049109:Cell Proliferation; D002633:Chemotaxis; D002642:Chick Embryo; D049033:Chorioallantoic Membrane; D019483:Disintegrins / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D005910:Glioma / Q000098:blood supply* / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D007124:Immunoenzyme Techniques; D016023:Integrins / Q000378:metabolism*; D009389:Neovascularization, Pathologic; D020932:Nerve Growth Factor / Q000494:pharmacology*; D011784:Quail; D014757:Viper Venoms / Q000494:pharmacology
chemical_list: D019483:Disintegrins; D016023:Integrins; D014757:Viper Venoms; C521210:bitisgabonin-2; C113256:integrin alpha 9 beta 1; D020932:Nerve Growth Factor